Plamen Kozlovski

988 total citations · 1 hit paper
18 papers, 639 citations indexed

About

Plamen Kozlovski is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Plamen Kozlovski has authored 18 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Surgery and 4 papers in Genetics. Recurrent topics in Plamen Kozlovski's work include Diabetes Treatment and Management (16 papers), Diabetes Management and Research (12 papers) and Pancreatic function and diabetes (8 papers). Plamen Kozlovski is often cited by papers focused on Diabetes Treatment and Management (16 papers), Diabetes Management and Research (12 papers) and Pancreatic function and diabetes (8 papers). Plamen Kozlovski collaborates with scholars based in United States, Switzerland and United Kingdom. Plamen Kozlovski's co-authors include Wolfgang Kothny, Valentina Lukashevich, James E. Foley, Anne Dornhorst, Simon Heller, Séamus Sreenan, Q. Shao, John J.V. McMurray, Henry Krum and Geremia B. Bolli and has published in prestigious journals such as Diabetes Care, American Heart Journal and Obesity.

In The Last Decade

Plamen Kozlovski

18 papers receiving 609 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Design and Rationale of Lp(a)HORIZON Trial: Assessing the Effect of Lipoprotein(a) Lowering With Pelacarsen on Major Cardiovascular Events in Patients With CVD and Elevated Lp(a)

2025 21 citations Leslie Cho, Stephen J. Nicholls et al. American Heart Journal profile →

Peers

Countries citing papers authored by Plamen Kozlovski

Since Specialization

Citations

This map shows the geographic impact of Plamen Kozlovski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Plamen Kozlovski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Plamen Kozlovski more than expected).

Fields of papers citing papers by Plamen Kozlovski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Plamen Kozlovski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Plamen Kozlovski. The network helps show where Plamen Kozlovski may publish in the future.

Co-authorship network of co-authors of Plamen Kozlovski

This figure shows the co-authorship network connecting the top 25 collaborators of Plamen Kozlovski. A scholar is included among the top collaborators of Plamen Kozlovski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Plamen Kozlovski. Plamen Kozlovski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Design and Rationale of Lp(a)HORIZON Trial: Assessing the Effect of Lipoprotein(a) Lowering With Pelacarsen on Major Cardiovascular Events in Patients With CVD and Elevated Lp(a) breakdown → 2025 ·American Heart Journal ·Leslie Cho, Stephen J. Nicholls, Børge G. Nordestgaard, (unknown), Sotirios Tsimikas, Michael J. Blaha, Eran Leitersdorf, A. Michael Lincoff, Anastasia Lesogor, Brian J. Manning, Plamen Kozlovski, (unknown), Jing Wang, Steven E. Nissen	21
2	Licogliflozin, a Novel SGLT1 and 2 Inhibitor: Body Weight Effects in a Randomized Trial in Adults with Overweight or Obesity 2020 ·Obesity ·Harold Bays, Plamen Kozlovski, Qing Shao, Pieter Proot, Deborah Keefe	32
3	Effects of the dual sodium–glucose linked transporter inhibitor, licogliflozin vs placebo or empagliflozin in patients with type 2 diabetes and heart failure 2020 ·British Journal of Clinical Pharmacology ·Rudolf A. de Boer, Julio Núñez, Plamen Kozlovski, (unknown), Pieter Proot, Deborah Keefe	35
4	DPP-4 inhibitor treatment: β-cell response but not HbA<sub>1c</sub> reduction is dependent on the duration of diabetes 2017 ·Vascular Health and Risk Management ·Plamen Kozlovski, Vaishali Bhosekar, James E. Foley	9
5	Factors that may Account for Cardiovascular Risk Reduction with a Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, in Young Patients with Type 2 Diabetes Mellitus 2017 ·Diabetes Therapy ·Marc Evans, Plamen Kozlovski, Päivi M. Paldánius, James E. Foley, Vaishali Bhosekar, (unknown), Angelo Avogaro	7
6	Clinical Safety and Tolerability of Vildagliptin – Insights from Randomised Trials, Observational Studies and Post-marketing Surveillance 2017 ·touchREVIEWS in Endocrinology ·Chantal Mathieu, Plamen Kozlovski, (unknown), Päivi M. Paldánius, (unknown), James E. Foley, (unknown), (unknown), Marc Evans, (unknown), (unknown)	30
7	Effects of Vildagliptin on Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure 2017 ·JACC Heart Failure ·John J.V. McMurray, Piotr Ponikowski, Geremia B. Bolli, Valentina Lukashevich, Plamen Kozlovski, Wolfgang Kothny, James Lewsey, Henry Krum	119
8	Effect of race and ethnicity on vildagliptin efficacy: A pooled analysis of phase II and III studies 2016 ·Diabetes Obesity and Metabolism ·Plamen Kozlovski, (unknown), Viswanathan Mohan, Valentina Lukashevich, Masato Odawara, Päivi M. Paldánius, Wolfgang Kothny	11
9	Vildagliptin added to sulfonylurea improves glycemic control without hypoglycemia and weight gain in Chinese patients with type 2 diabetes mellitus 中国2型糖尿病患者使用磺脲类药物联合维格列汀可改善血糖控制且无低血糖及体重增加 2014 ·Journal of Diabetes ·Wenying Yang, Xiaoping Xing, Xiaofeng Lv, Yiming Li, Jianhua Ma, Guoyue Yuan, Feifei Sun, Wei Wang, Michael Woloschak, Valentina Lukashevich, Plamen Kozlovski, Wolfgang Kothny, (unknown)	18
10	Study to determine the durability of glycaemic control with early treatment with a vildagliptin–metformin combination regimen vs. standard‐of‐care metformin monotherapy—the VERIFY trial: a randomized double‐blind trial 2014 ·Diabetic Medicine ·Stefano Del Prato, James E. Foley, Wolfgang Kothny, Plamen Kozlovski, Michael Stümvoll, Päivi M. Paldánius, David R. Matthews	34
11	Vildagliptin-insulin combination improves glycemic control in Asians with type 2 diabetes 2013 ·World Journal of Diabetes ·Plamen Kozlovski	13
12	Meta‐analysis of insulin aspart versus regular human insulin used in a basal–bolus regimen for the treatment of diabetes mellitus (在基础—餐时糖尿病治疗方案中使用门冬胰岛素与使用常规人胰岛素对照研究的Meta分析) 2013 ·Journal of Diabetes ·Simon Heller, Bruce W. Bode, Plamen Kozlovski, Anne Louise Svendsen	12
13	Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus 2012 ·Diabetes Obesity and Metabolism ·Wolfgang Kothny, James E. Foley, Plamen Kozlovski, Q. Shao, Baptist Gallwitz, Valentina Lukashevich	87
14	Initiation with once-daily BIAsp 30 results in superior outcome compared to insulin glargine in Asians with type 2 diabetes inadequately controlled by oral anti-diabetic drugs 2010 ·Diabetes Research and Clinical Practice ·(unknown), (unknown), (unknown), (unknown), Flemming L. Søndergaard, Plamen Kozlovski, Wan Mohamad Wan Bebakar	24
15	Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVETM study 2008 ·International Journal of Clinical Practice ·Anne Dornhorst, (unknown), Séamus Sreenan, Plamen Kozlovski, Jes B. Hansen, (unknown), Luigi Meneghini, (unknown)	65
16	Insulin's 85th anniversary—An enduring medical miracle 2007 ·Diabetes Research and Clinical Practice ·Simon Heller, Plamen Kozlovski, Peter Kurtzhals	38
17	PREDICTIVE™– a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort 2006 ·Diabetes Obesity and Metabolism ·(unknown), Séamus Sreenan, Stefan Aczél, Stephan Maxeiner, Mustafa Yenigün, Plamen Kozlovski, Helge Gydesen, Anne Dornhorst, (unknown)	70
18	Effect of Structured Group Education on Glycemic Control and Hypoglycemia in Insulin-Treated Patients 2003 ·Diabetes Care ·D Koev, Tsvetalina Tankova, Plamen Kozlovski	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact